Cardioprotective Effect of Trimetazidine during Thrombolytic Therapy in Patients with Acute Myocardial Infarction.

Rebrova TY; Lasukova TV; Afanasev SA; Perchatkin VA; Maksimov IV; Markov VA

首页> 外文期刊>Bulletin of experimental biology and medicine >Cardioprotective Effect of Trimetazidine during Thrombolytic Therapy in Patients with Acute Myocardial Infarction.

【24h】

Cardioprotective Effect of Trimetazidine during Thrombolytic Therapy in Patients with Acute Myocardial Infarction.

机译：曲美他嗪在溶栓治疗期间对急性心肌梗死患者的心脏保护作用。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

We studied the cardioprotective effect of anti-ischemic drug trimetazidine in the thrombolytic therapy of acute myocardial infarction. Trimetazidine (60 mg/day) effectively inhibits lipid peroxidation and moderates reperfusion damage to the myocardium assessed by ECG, QRS index of damaged heart, and release of creatine phosphokinase into circulation.

机译：我们研究了抗缺血药物曲美他嗪在急性心肌梗塞溶栓治疗中的心脏保护作用。 Trimetazidine（60 mg / day）有效抑制脂质过氧化，并减轻通过ECG，受损心脏的QRS指数和肌酸磷酸激酶释放进入循环所评估的心肌再灌注损伤。

著录项

来源
《Bulletin of experimental biology and medicine》 |2002年第6期|共3页
作者
Rebrova TY; Lasukova TV; Afanasev SA; Perchatkin VA; Maksimov IV; Markov VA;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类基础医学;
关键词
Trimetazidine; Thrombolytic Therapy; Effective; Acute; Myocardial Infarction; 曲美他嗪; 血栓溶解疗法; 心肌梗塞;

机译：Trimetazidine;Thrombolytic Therapy;Effective;Acute;Myocardial Infarction;曲美他嗪;血栓溶解疗法;心肌梗塞;

相似文献

外文文献
中文文献
专利

1. Cardioprotective Effect of Trimetazidine during Thrombolytic Therapy in Patients with Acute Myocardial Infarction. [J] . Rebrova TY, Lasukova TV, Afanasev SA, Bulletin of experimental biology and medicine . 2002,第6期

机译：曲美他嗪在溶栓治疗期间对急性心肌梗死患者的心脏保护作用。
2. Low levels of plasma soluble complement receptor type 1 in patients receiving thrombolytic therapy for acute myocardial infarction. [J] . Karthikeyan G, Baalasubramanian S, Seth S, Journal of thrombosis and thrombolysis . 2007,第2期

机译：接受溶栓治疗急性心肌梗死的患者中1型血浆可溶性补体受体水平低。
3. Admission plasma leptin level strongly correlates with the success of thrombolytic therapy in patients with acute myocardial infarction. [J] . Amasyali B, Aytemir K, Kose S, Angiology: the Journal of Vascular Diseases . 2006,第6期

机译：急性心肌梗塞患者的血浆瘦素水平与溶栓治疗的成功密切相关。
4. Clinical Presentation, Outcome and Therapy in Patients with Acute Myocardial Infarction. Correlation with Demographic Factors -A RO-STEMI Analysis Report [C] . D. Tint, M. RSdoi, Gh. Pamfil, International Congress on Coronary Artery Disease . 2007

机译：急性心肌梗死患者的临床介绍，结果和治疗。与人口统计因子的相关性-a ro-steni分析报告
5. A Peptide Modified Hydrogel Therapy for Acute Myocardial Infarction. [D] . Reis, Lewis A. 2015

机译：急性心肌梗死的肽修饰水凝胶疗法。
6. Guidelines for the use of intravenous thrombolytic agents in acute myocardial infarction. Ontario Medical Association Consensus Group on Thrombolytic Therapy. [O] . C D Naylor, P W Armstrong 1989

机译：在急性心肌梗死中使用静脉溶栓剂的指南。安大略省医学协会溶栓治疗共识小组。
7. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II. [O] . H S Mueller, L S Cohen, E Braunwald, 1992

机译：急性心肌梗死溶栓治疗后早期发病率和死亡率的预测因素。 II期心肌梗死溶栓中患者亚组分析。

Cardioprotective Effect of Trimetazidine during Thrombolytic Therapy in Patients with Acute Myocardial Infarction.

摘要

著录项

相似文献

相关主题

期刊订阅